PCP4 expression is significantly altered in a region-specific manner in AD and Huntington’s disease (HD) patient brains, potentially contributing to neurodegeneration through the disruption of calmodulin signaling [62]. The gene discussed is PCP4; the disease is juvenile Huntington disease.